GR850787B - - Google Patents

Info

Publication number
GR850787B
GR850787B GR850787A GR850100787A GR850787B GR 850787 B GR850787 B GR 850787B GR 850787 A GR850787 A GR 850787A GR 850100787 A GR850100787 A GR 850100787A GR 850787 B GR850787 B GR 850787B
Authority
GR
Greece
Prior art keywords
derivative
benzyl
condensing
addition salt
acid addition
Prior art date
Application number
GR850787A
Other languages
Greek (el)
English (en)
Inventor
Hiroshi Ohtaka
Toshiro Kanazawa
Keizo Ito
Goro Tsukamoto
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Publication of GR850787B publication Critical patent/GR850787B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GR850787A 1984-03-30 1985-03-28 GR850787B (Direct)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59064464A JPS60222472A (ja) 1984-03-30 1984-03-30 新規なピペラジン誘導体および該化合物を有効成分とする医薬組成物

Publications (1)

Publication Number Publication Date
GR850787B true GR850787B (Direct) 1985-11-25

Family

ID=13258978

Family Applications (1)

Application Number Title Priority Date Filing Date
GR850787A GR850787B (Direct) 1984-03-30 1985-03-28

Country Status (10)

Country Link
US (1) US4663325A (Direct)
EP (1) EP0159566B1 (Direct)
JP (1) JPS60222472A (Direct)
AT (1) ATE31411T1 (Direct)
CA (1) CA1248110A (Direct)
DE (1) DE3561199D1 (Direct)
ES (3) ES8702393A1 (Direct)
FI (1) FI79101C (Direct)
GR (1) GR850787B (Direct)
NO (1) NO163185C (Direct)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61161272A (ja) * 1985-01-11 1986-07-21 Kanebo Ltd 新規なピペラジン誘導体および該化合物を有効成分とする医薬組成物
US4792553A (en) * 1986-02-04 1988-12-20 Terumo Kabushiki Kaisha Diene derivatives and vasodilators containing the same
FR2614021B1 (fr) * 1987-04-14 1991-03-01 Andre Buzas Derives de la 1-((1,1-diphenyl)-1-alcenyl)-piperazine, procede d'obtention et compositions pharmaceutiques les contenant
DE4108527A1 (de) * 1991-03-15 1992-09-17 Basf Ag Neue 1-(4-cyano-4-aryl-cyclohexyl)piperazine, ihre herstellung und verwendung
AU646926B2 (en) * 1991-03-20 1994-03-10 Duphar International Research B.V. Alkylenedioxyphenyl ether derivatives having anti-ischaemic, memory enhancing and anti-convulsive activity
CA2153979C (en) * 1993-12-08 2003-10-21 Mark Hellberg Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
KR100585299B1 (ko) * 1998-01-29 2006-06-01 악조 노벨 엔.브이. 시신경유두 순환 개선제
RU2204556C2 (ru) * 2001-06-18 2003-05-20 Федеральное государственное унитарное предприятие "Новокузнецкий научно-исследовательский химико-фармацевтический институт" Способ получения 1-(парахлорбензгидрил)-4-(2-оксиэтил)пиперазина
BR0313593A (pt) 2002-08-19 2005-07-12 Pfizer Prod Inc Terapia de combinação para doenças hiperproliferativas
US7403561B2 (en) 2003-04-04 2008-07-22 Avid Technology, Inc. Fixed bit rate, intraframe compression and decompression of video
US7433519B2 (en) 2003-04-04 2008-10-07 Avid Technology, Inc. Bitstream format for compressed image data
US20050159403A1 (en) * 2003-04-22 2005-07-21 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of central nervous system damage
WO2004093813A2 (en) * 2003-04-22 2004-11-04 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of pain, inflammation or inflammation mediated disorders
OA13174A (en) * 2003-05-30 2006-12-13 Ranbaxy Lab Ltd Substituted pyrrole derivatives and their use as HMG-Co inhibitors.
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
US20060205727A1 (en) * 2005-03-11 2006-09-14 Wayne Kaesemeyer Combination therapy for endothelial dysfunction, angina and diabetes
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
EP2351569B1 (en) 2005-10-26 2012-08-22 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
EP1951253A2 (en) * 2005-10-26 2008-08-06 Cotherix, Inc. Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
WO2007054896A1 (en) * 2005-11-08 2007-05-18 Ranbaxy Laboratories Limited Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
WO2008020314A2 (en) * 2006-03-14 2008-02-21 Ranbaxy Laboratories Limited Statin stabilizing dosage formulations
WO2008010087A2 (en) * 2006-07-14 2008-01-24 Ranbaxy Laboratories Limited Polymorphic forms of an hmg-coa reductase inhibitor and uses thereof
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
WO2008105442A1 (ja) 2007-02-28 2008-09-04 Asahi Kasei Pharma Corporation スルホンアミド誘導体
WO2012037665A1 (en) 2010-09-24 2012-03-29 Oral Delivery Technology Ltd. Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
CN102936233B (zh) * 2012-11-16 2016-01-20 葛长乐 一种1-(二(4-氟苯基)甲基)-4-(2,3,4-三甲氧苯基)哌嗪二盐酸盐晶型
JP2016516804A (ja) 2013-04-17 2016-06-09 ファイザー・インク 心血管疾患を治療するためのｎ−ピペリジン−３−イルベンズアミド誘導体
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
WO2017069343A1 (ko) * 2015-10-20 2017-04-27 한국표준과학연구원 위치조절이 용이한 전자현미경용 전자총 및 이를 포함하는 전자현미경
CN109666008A (zh) * 2018-12-31 2019-04-23 辰欣药业股份有限公司 一种盐酸洛美利嗪的合成方法
AU2020209215B2 (en) 2019-01-18 2023-02-02 Astrazeneca Ab PCSK9 inhibitors and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB705979A (en) * 1951-03-22 1954-03-24 Henri Morren 1.4-aralkyl piperazines and process for the preparation thereof
FR1312427A (fr) * 1961-04-12 1962-12-21 Science Union Et Compagnie Soc Nouveaux dérivés de la pipérazine et leurs préparations
FR1303080A (fr) * 1961-07-25 1962-09-07 Science Union Et Compagnie Soc Pipérazines disubstituées
NL7306771A (Direct) * 1972-06-02 1973-12-04
DE2900810A1 (de) * 1979-01-11 1980-07-24 Cassella Ag Substituierte n-benzhydryl-n'-p- hydroxybenzyl-piperazine und verfahren zu ihrer herstellung
GB8320701D0 (en) * 1983-08-01 1983-09-01 Wellcome Found Chemotherapeutic agent

Also Published As

Publication number Publication date
NO851298L (no) 1985-10-01
DE3561199D1 (en) 1988-01-28
JPS60222472A (ja) 1985-11-07
ATE31411T1 (de) 1988-01-15
US4663325A (en) 1987-05-05
FI79101C (fi) 1989-11-10
JPH0313232B2 (Direct) 1991-02-22
NO163185C (no) 1990-04-18
CA1248110A (en) 1989-01-03
ES8702393A1 (es) 1987-01-01
ES541728A0 (es) 1987-01-01
ES556981A0 (es) 1988-01-01
ES556980A0 (es) 1988-01-01
EP0159566A1 (en) 1985-10-30
FI79101B (fi) 1989-07-31
ES8801236A1 (es) 1988-01-01
EP0159566B1 (en) 1987-12-16
FI851217L (fi) 1985-10-01
FI851217A0 (fi) 1985-03-26
ES8801237A1 (es) 1988-01-01

Similar Documents

Publication Publication Date Title
GR850787B (Direct)
KR830006228A (ko) 이미다졸 유도체의 제조방법
ATE17249T1 (de) 9-(2-(3-indolyl)aethyl)-1-oxa-4,9diazaspiro(5.5)undecan-3-one.
AU518470B2 (en) 2-(2-alkoxyethyl)-2:-hydroxy-6,7-benzomorphanes
KR890005086A (ko) 1-[(2- 피리미디닐) 아미노알킬]피페리딘, 그의 제법 및 치료에의 이용
DK0453365T3 (da) Fremgangsmåde til fremstilling af 1-(2,3,4-trimethoxybenzyl)piperazin ved reduktiv aminering
ES504206A0 (es) Procedimiento para la preparacion de nuevas 5,10-dihidro -11h-dibenzo b,e 1,4 diazepin-11-onas, sustituidas en posi- cion 5
KR930703312A (ko) 아자비사이클로 [2.2.2]옥탄-3-이민의 제조방법 및 그의 제조용 중간체
KR860003239A (ko) 퀴놀론 카복실산 유도체의 제조방법
ATE31527T1 (de) P-oxibenzoesaeurederivate, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von arzneimitteln mit hypolipaemischer wirkung.
KR840001152A (ko) 신규 복소환(複素環) 화합물의 제법
HU9202430D0 (en) Method for producing 6-oxo-azepino-indole compounds
DE3264928D1 (en) Process for producing brominated 1,3-dioxolen-2-ones
KR950703515A (ko) 신규 n,n,n',n'-2치환-1,2-에탄디아민 유도체 화합물(new n,n,n',n'-tetrasubstituted-1,2-ethanediamine derivative compounds)
SE8502007L (sv) Cyklopentanderivat och sett for framstellning derav
ES453787A1 (es) Un procedimiento para la preparacion de compuestos de nido- lina.
JPS5618958A (en) Preparation of n- d-alpha-methyl-beta-mercaptopropionyl -l- proline derivative
IE44951L (en) Pyridoindoles
ES8705454A1 (es) Procedimiento para la obtencion de derivados del acido imidazoalquenoico
ATE33837T1 (de) Azolylmethylcycloacetale, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ES8106143A1 (es) Procedimiento para la preparacion de derivados de cinamoil- piperidinobutirofenona
ES8801263A1 (es) Procedimiento para la preparacion de derivados de 10 l-metoxi-6-metilergolina y sus sales de adicion de acidos
ES8204435A1 (es) Un procedimiento para la preparacion de 2-(1-piperacinil)-4-(pirimidinaminas)
KR860004008A (ko) 부타놀유도체의 제법
KR840004438A (ko) 세팔로스포린 유도체의 제조방법